Firefly Neuroscience (AIFF) Cash from Investing Activities (2010 - 2026)
Firefly Neuroscience (AIFF) posted Cash from Investing Activities of -$42000.0 for Q2 2026, up 27.59% on a QoQ basis from -$58000.0 in Q1 2026, and up 98.23% year-over-year from -$21187.6 in Q2 2025.
Powered by 
Analysis
Firefly Neuroscience (AIFF) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Firefly Neuroscience has reported Cash from Investing Activities for 17 years, with the latest figure at -$42000.0 in Q2 2026.
- On a quarterly basis, Cash from Investing Activities rose 98.23% year-over-year to -$42000.0 in Q2 2026; TTM through Jun 2026 was -$209000.0, a 93.24% increase from a year earlier, with the FY2025 full-year figure at -$2.5 million, down 421.59% from the prior year.
- Cash from Investing Activities was -$42000.0 for Q2 2026 at Firefly Neuroscience, up from -$58000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $935974.0 in Q1 2023, with the low at -$2.4 million in Q2 2025.
- Average Cash from Investing Activities over 5 years is -$272118.9, with a median of -$108500.0 recorded in 2024.
- The sharpest annual moves came in 2023 and 2026: Cash from Investing Activities soared 8050.17% in 2023, then sank 728.57% in 2026.
- Over 5 years, Cash from Investing Activities stood at -$301842.0 in 2022, then declined by 27.88% to -$386000.0 in 2023, then fell by 3.89% to -$401000.0 in 2024, then jumped by 94.26% to -$23000.0 in 2025, then tumbled by 82.61% to -$42000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$42000.0 (Q2 2026), -$58000.0 (Q1 2026), and -$23000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | -115.00 Mn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | -2.02 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | -4.00 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | -974,000.00 |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | -107.30 Mn |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | -606,000.00 |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | -6.30 Mn |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 | -42,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -42,000.00 |
| Mar 31, 2026 | -58,000.00 |
| Dec 31, 2025 | -23,000.00 |
| Sep 30, 2025 | -86,000.00 |
| Jun 30, 2025 | -2.37 Mn |
| Mar 31, 2025 | -7,000.00 |
| Sep 30, 2024 | -401,000.00 |
| Jun 30, 2024 | -312,000.00 |
| Mar 31, 2024 | -131,000.00 |
| Dec 31, 2023 | -386,000.00 |
| Sep 30, 2023 | -935,974.00 |
| Mar 31, 2023 | 935,974.00 |
| Dec 31, 2022 | -301,842.00 |
| Sep 30, 2022 | -203,027.00 |
| Jun 30, 2022 | -19,260.00 |
| Mar 31, 2022 | -11,773.00 |
| Dec 31, 2021 | -7.29 Mn |
| Sep 30, 2021 | -33,556.00 |
| Jun 30, 2021 | -2.25 Mn |
| Mar 31, 2021 | -4,612.00 |